Citigroup Upgrades Adient to Buy, Raises Price Target to $33
Benzinga Newsdesk 6 months ago
NewsUpgradesPrice TargetAnalyst Ratings
Citigroup analyst Michael Ward upgrades Adient (NYSE:ADNT) from Neutral to Buy and raises the price target from $30 to $33.
Citigroup analyst Michael Ward upgrades Adient (NYSE:ADNT) from Neutral to Buy and raises the price target from $30 to $33.